Healthcare · Pharmaceutical expenditure
Australia's pharmaceutical expenditure in 2026 reached 2 % GDP of GDP, placing the country 12-th out of 197. This figure reflects a balanced policy: the government's Pharmaceutical Benefits Scheme (PBS) subsidizes a wide range of medicines, making them affordable while strictly controlling prices. The high share of spending is driven by growing demand for innovative drugs and an aging population, particularly in coastal urban agglomerations.
Data for 2026 · unit: % GDP
Position
#12 / 197
Australia world ranking
Country position on the scale from last to first place for this indicator.
AU
#12
#197#1
Trend
Change over time
Change in indicator over the available period.
1.50
1990
1.70
2000
1.90
2010
1.80
2020
2.00
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Australia stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Australia — how much?
Based on 2026 data — 2 % GDP. This is rank #12 out of 197 countries.
What is Australia's rank by Pharmaceutical expenditure?
Australia ranks #12 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Australia?
Over the available period the indicator changed from 1.50 to 2 % GDP.